HT942523D0018 MODIFICATION NOTICE OF INTENT
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
ARMY MED RES ACQ ACTIVITY
Contract Value
Not provided
Codes & Classification
Solicitation Number
HT942523D0018
NAICS
-
Classification Code
-
Additional Details
The U.S. Army Medical Research Acquisition Activity (USAMRAA), acting on behalf of the U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID), has issued a Sources Sought Notice indicating its intent to modify existing contract HT942523D0018. This contract, originally awarded to Trillamed LLC on September 22, 2023, is structured as an Indefinite Delivery/Indefinite Quantity (IDIQ) agreement. The primary objectives of this procurement are twofold: first, to replace biocontainment sterilizer units—including the removal and disposal of current units, installation of new units equipped with biocontainment bioseals, and subsequent certification and validation; and second, to upgrade the software operating controls of existing pass-through biocontainment autoclaves.
This modification is intended to be executed on a sole source basis, as Trillamed LLC was the only offeror during the initial full and open competitive solicitation for this commercial requirement. The notice serves to fulfill the synopsis requirements under FAR 5.2 and clarifies that this is not a request for quotations (RFQ); no solicitation document is available for this requirement. However, the government invites interested vendors who believe they possess the requisite capabilities to submit a detailed capability statement. Such statements must provide compelling evidence of the vendor’s ability to deliver the specified supplies and services. The government will use any responses solely to determine whether to open the procurement to competition or proceed with the sole source modification. The final decision to compete or not remains at the government’s discretion.
Key requirements for this contract include the comprehensive replacement of biocontainment sterilizer units, ensuring proper removal and disposal of outdated equipment, installation of new units with advanced biocontainment features, and thorough certification and validation processes. Additionally, the contract encompasses the upgrade of software controls for existing biocontainment autoclaves, ensuring continued compliance with stringent operational and safety standards critical to USAMRIID’s mission.
The contracting entity is the Army Medical Research Acquisition Activity, a federal office, with primary contact Emily O’Hara ([email protected], 301-619-9599). Capability statements must be submitted electronically in Microsoft Word or Adobe PDF format to both [email protected] and [email protected]. No phone inquiries will be accepted. The deadline for submission is 1300 Eastern Time on August 10, 2025.
This opportunity is classified as a Sources Sought Notice and is currently active. Contractors with expertise in biocontainment sterilizer systems, autoclave software upgrades, and related validation processes are encouraged to review the notice in detail and consider submitting a capability statement if they can meet the outlined requirements. The notice and further details can be accessed via the official SAM.gov listing at https://sam.gov/opp/8af47bd7dc924aab9cc585f79261ef1b/view.